Tet1 deficiency exacerbates oxidative stress in acute kidney injury by regulating superoxide dismutase
暂无分享,去创建一个
Chengyu Liu | Anlin Peng | MingRui Xiong | Yangmian Yuan | Ling Zheng | Dong Yang | Yu Fan | Muchuan Jin | Kun Huang | Donge Zhang | Robert B. Petersen
[1] Dong Yang,et al. An antioxidant feedforward cycle coordinated by linker histone variant H1.2 and NRF2 that drives nonsmall cell lung cancer progression , 2023, Proceedings of the National Academy of Sciences of the United States of America.
[2] Anlin Peng,et al. A renal YY1-KIM1-DR5 axis regulates the progression of acute kidney injury , 2023, Nature communications.
[3] Chengyu Liu,et al. Linker histone variant H1.2 is a brake on white adipose tissue browning , 2023, Nature communications.
[4] R. Petersen,et al. Tubular Elabela-APJ axis attenuates ischemia-reperfusion induced acute kidney injury and the following AKI-CKD transition by protecting renal microcirculation , 2023, Theranostics.
[5] Dong Yang,et al. Loss of renal tubular G9a benefits acute kidney injury by lowering focal lipid accumulation via CES1 , 2023, EMBO reports.
[6] M. Savitski,et al. Control of protein stability by post-translational modifications , 2023, Nature Communications.
[7] Elizabeth H. Chen,et al. YAP induces an oncogenic transcriptional program through TET1-mediated epigenetic remodeling in liver growth and tumorigenesis , 2022, Nature Genetics.
[8] Z. Dong,et al. Inflammation in kidney repair: Mechanism and therapeutic potential. , 2022, Pharmacology & therapeutics.
[9] Qian Wang,et al. Renal UTX-PHGDH-serine axis regulates metabolic disorders in the kidney and liver , 2022, Nature Communications.
[10] Chengyu Liu,et al. Mecp2 protects kidney from ischemia-reperfusion injury through transcriptional repressing IL-6/STAT3 signaling , 2022, Theranostics.
[11] Yuyan Sun,et al. Histone H1.2 promotes hepatocarcinogenesis by regulating signal transducer and activator of transcription 3 signaling , 2022, Cancer Science.
[12] Hong Chen,et al. Histone demethylase UTX aggravates acetaminophen overdose induced hepatotoxicity through dual mechanisms. , 2021, Pharmacological research.
[13] Yuanyuan Fu,et al. A-Lipoic Acid Alleviates Folic Acid-Induced Renal Damage Through Inhibition of Ferroptosis , 2021, Frontiers in Physiology.
[14] Guangtao Xu,et al. Allicin ameliorates renal ischemia/reperfusion injury via inhibition of oxidative stress and inflammation in rats. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[15] Chengyu Liu,et al. Vitamin C Inhibits the Metabolic Changes Induced by Tet1 Insufficiency Under High Fat Diet Stress. , 2021, Molecular nutrition & food research.
[16] J. Pedraza-Chaverri,et al. Redox signaling pathways in unilateral ureteral obstruction (UUO)-induced renal fibrosis. , 2021, Free radical biology & medicine.
[17] Yizhuo Wang,et al. Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance , 2021, Theranostics.
[18] Wenjuan Wang,et al. TET-mediated DNA demethylation plays an important role in arsenic-induced HBE cells oxidative stress via regulating promoter methylation of OGG1 and GSTP1. , 2020, Toxicology in vitro : an international journal published in association with BIBRA.
[19] A. Vijayan. Tackling AKI: prevention, timing of dialysis and follow-up , 2020, Nature Reviews Nephrology.
[20] X. Lan,et al. PEGylated and Acylated Elabela Analogues Show Enhanced Receptor Binding, Prolonged Stability, and Remedy of Acute Kidney Injury. , 2020, Journal of medicinal chemistry.
[21] R. Petersen,et al. Muscular G9a Regulates Muscle-Liver-Fat Axis by Musclin Under Overnutrition in Female Mice , 2020, Diabetes.
[22] Ying Yao,et al. XJB-5-131 inhibited ferroptosis in tubular epithelial cells after ischemia−reperfusion injury , 2020, Cell Death & Disease.
[23] Xiaoqiang Ding,et al. Hydrogen sulfide attenuates renal fibrosis by inducing TET‐dependent DNA demethylation on Klotho promoter , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[24] J. Cang,et al. Ten-eleven translocation methyl-cytosine dioxygenase 2 deficiency exacerbates renal ischemia-reperfusion injury , 2020, Clinical Epigenetics.
[25] Rongqian Wu,et al. Involvement of GPX4 in irisin's protection against ischemia reperfusion‐induced acute kidney injury , 2020, Journal of cellular physiology.
[26] Jiucun Wang,et al. TET1 promotes fatty acid oxidation and inhibits NAFLD progression by hydroxymethylation of PPARα promoter , 2020, Nutrition & Metabolism.
[27] R. Petersen,et al. Multi-generational maternal obesity increases the incidence of HCC in offspring via miR-27a-3p. , 2020, Journal of hepatology.
[28] Guian Huang,et al. Tet1 Deficiency Leads to Premature Reproductive Aging by Reducing Spermatogonia Stem Cells and Germ Cell Differentiation , 2020, iScience.
[29] Zhongbo Zhang,et al. Ruxolitinib Alleviates Renal Interstitial Fibrosis in UUO Mice , 2020, International journal of biological sciences.
[30] M. Ehrlich. DNA hypermethylation in disease: mechanisms and clinical relevance , 2019, Epigenetics.
[31] Xiujing Feng,et al. Dexmedetomidine Ameliorates Acute Stress-Induced Kidney Injury by Attenuating Oxidative Stress and Apoptosis through Inhibition of the ROS/JNK Signaling Pathway , 2018, Oxidative medicine and cellular longevity.
[32] M. Abdel-Bakky,et al. Tempol, a superoxide dismutase mimetic agent, reduces cisplatin-induced nephrotoxicity in rats , 2018, Drug and chemical toxicology.
[33] D. Nakano,et al. Acute kidney injury to chronic kidney disease transition: insufficient cellular stress response , 2018, Current opinion in nephrology and hypertension.
[34] L. Pnueli,et al. Tet Enzymes, Variants, and Differential Effects on Function , 2018, Front. Cell Dev. Biol..
[35] A. Resende,et al. Tempol, a superoxide dismutase-mimetic drug, prevents chronic ischemic renal injury in two-kidney, one-clip hypertensive rats , 2018, Clinical and experimental hypertension.
[36] Juan Du,et al. Tet1 facilitates hypoxia tolerance by stabilizing the HIF-α proteins independent of its methylcytosine dioxygenase activity , 2017, Nucleic acids research.
[37] Hong Chen,et al. ELABELA and an ELABELA Fragment Protect against AKI. , 2017, Journal of the American Society of Nephrology : JASN.
[38] P. Bhargava,et al. Mitochondrial energetics in the kidney , 2017, Nature Reviews Nephrology.
[39] Jinu Kim. Poly(ADP-ribose) polymerase activation induces high mobility group box 1 release from proximal tubular cells during cisplatin nephrotoxicity. , 2016, Physiological research.
[40] Hui-ping Wang,et al. Protective Effect of Tempol on Acute Kidney Injury Through PI3K/Akt/Nrf2 Signaling Pathway , 2016, Kidney and Blood Pressure Research.
[41] F. Ciccarone,et al. 5mC-hydroxylase activity is influenced by the PARylation of TET1 enzyme , 2015, Oncotarget.
[42] J. Bonventre,et al. Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD , 2015, Nature Reviews Nephrology.
[43] Xian Chen,et al. CRL4(VprBP) E3 ligase promotes monoubiquitylation and chromatin binding of TET dioxygenases. , 2015, Molecular cell.
[44] Zilong Qiu,et al. Tet1-mediated DNA demethylation regulates neuronal cell death induced by oxidative stress , 2015, Scientific Reports.
[45] Qiang Shu,et al. From development to diseases: the role of 5hmC in brain. , 2014, Genomics.
[46] R. Kalluri,et al. Tet3-mediated hydroxymethylation of epigenetically silenced genes contributes to bone morphogenic protein 7-induced reversal of kidney fibrosis. , 2014, Journal of the American Society of Nephrology : JASN.
[47] C. Franceschi,et al. Poly(ADP-ribosyl)ation is involved in the epigenetic control of TET1 gene transcription , 2014, Oncotarget.
[48] M. Sánchez-Niño,et al. Unilateral ureteral obstruction: beyond obstruction , 2014, International Urology and Nephrology.
[49] Yi Zhang,et al. TET enzymes, TDG and the dynamics of DNA demethylation , 2013, Nature.
[50] Dan Liu,et al. Ten-Eleven Translocation 1 (Tet1) Is Regulated by O-Linked N-Acetylglucosamine Transferase (Ogt) for Target Gene Repression in Mouse Embryonic Stem Cells* , 2013, The Journal of Biological Chemistry.
[51] V. Demarco,et al. Mineralocorticoid Receptor-Dependent Proximal Tubule Injury Is Mediated by a Redox-Sensitive mTOR/S6K1 Pathway , 2011, American Journal of Nephrology.
[52] Peng Jin,et al. 5-hmC–mediated epigenetic dynamics during postnatal neurodevelopment and aging , 2011, Nature Neuroscience.
[53] D. Page,et al. Tet1 is dispensable for maintaining pluripotency and its loss is compatible with embryonic and postnatal development. , 2011, Cell stem cell.
[54] Li Yang,et al. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury , 2010, Nature Medicine.
[55] S. Kiley,et al. Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy , 2010, Pediatric Nephrology.
[56] M. Rosner,et al. Acute kidney injury. , 2009, Current drug targets.
[57] B. Padanilam,et al. Poly(ADP-ribose) polymerase-mediated cell injury in acute renal failure. , 2005, Pharmacological research.
[58] R. Kalluri,et al. Low-dose hydralazine prevents fibrosis in a murine model of acute kidney injury-to-chronic kidney disease progression. , 2017, Kidney international.